Entresto 49 MG-51 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F9BVX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,010
Award facts
- Contract value 100% obligated
- $14,010.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) valued at $14,010.42 with a firm fixed price contract type. The order is scheduled for completion by December 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation and is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for military and federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive portfolio with the DLA encompasses a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Entresto, a combination medication used in cardiovascular treatment, aligns with AmerisourceBergen's established role as a preferred supplier of specialty pharmaceuticals within the DLA's global pharmaceutical support network. This order exemplifies the routine delivery order fulfillment under the larger indefinite delivery vehicle that enables flexible pharmaceutical procurement to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9BVX?
SPE2DR26F9BVX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9BVX worth?
The government has obligated $14,010 on SPE2DR26F9BVX.
Is contract SPE2DR26F9BVX an order under another contract?
Yes. SPE2DR26F9BVX is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BVX competed?
The extent of competition for SPE2DR26F9BVX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award